On March 11, Carl Qin, the General Manager at CR Capital Management, and his delegation involving Ni Bing, managing director of CR Everbright Health Industry FOF, and Dr. Gong Chunhe, executive director, investigated Hunan Kexin Health Industry Group. Chen Lihong, president of Kexin Group, Hu Zhenhu